In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 to an estimated $381.5 billion by 2033. Two pharmaceutical giants, Eli ...

Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals Vandana Singh Mon, Feb 10, 2025, 11:55 AM2 min read ...

Eli Lilly and Co. innovates with animal-free testing INDIANAPOLIS (WISH) — A pharmaceutical titan based in Indiana is leading a global effort to protect wildlife.

Business Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic The breakthrough puts the market one step closer to having a needle-free option to address obesity and diabetes.

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Eli Lilly says new data shows promising results for GLP-1 pill Drug maker Eli Lilly says data from a late-stage trial showed a reduction in weight of almost 8% in people with Type 2 diabetes.

On this episode of Stock Movers: - Eli Lilly (LLY) shares fell the most intraday since October after CVS Health announced a plan to drop its blockbuster weight-loss drug Zepbound from its ...

Lilly will build a $4.5B R&D and manufacturing facility. dubbed the Lilly Medicine Foundry, at the huge complex it is constructing in Lebanon, Indiana.

Eli Lilly expands its partnership with AdvanCell to advance targeted alpha therapies using Pb-212 technology for cancer treatment. Lilly inks a global licensing deal with OliX for OLX75016, a ...

On Monday, Eli Lilly And Co (NYSE:LLY) inked two strategic collaborations to expand radiopharmaceuticals and metabolic-associated steatohepatitis (MASH), respectively. AdvanCell announced that it ...